Pittcon announced that Alan G. Marshall, Kasha Professor of Chemistry and Biochemistry at Florida State University (Tallahassee, Florida) and director of the Ion Cyclotron Resonance Program at the National High Magnetic Field Laboratory, will be the plenary lecturer during the opening session on March 1 at Pittcon 2010.
Pittcon (Pittsburgh, Pennsylvania) announced that Alan G. Marshall, Kasha Professor of Chemistry and Biochemistry at Florida State University (Tallahassee, Florida) and director of the Ion Cyclotron Resonance Program at the National High Magnetic Field Laboratory will be the plenary lecturer during the opening session on March 1 at Pittcon 2010.
The conference will be held February 28 to March 5, 2010, in Orlando, Florida, at the Orange County Convention Center, West Building. Marshall’s presentation will focus on how high-end instrumentation has both advanced state-of-the-art applications and stimulated the performance of lower-end instrumentation. He will present examples drawn from cyclotrons, lasers, mass spectrometry, microscopy, NMR spectroscopy, Raman spectroscopy, and robots.
Marshall co-invented and continues to lead in the development of Fourier-transform ion cyclotron resonance mass spectrometry. His current research includes instrumentation development, fossil fuels and environmental analysis, and mapping the primary and higher-order structures of biological macromolecules and their complexes.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.